Q2 report 2022- a quarter with big commercial steps forward

Q2 report 2022- a quarter with big commercial steps forward

“Positive results from large clinical study on newborns, aquire of strategic IP assets and a reinforced board lay the foundation for successful commercial launch of the company’s medical device for continuous lung monitoring.”  CEO Hanna Sjöström  PM and...